Relative contributions of vaccination and previous infection to population-level SARS-CoV-2 immunity over time: a simulation modelling study
Szanyi, J.; Wilson, T.; Andrabi, H.; Blakely, T.
Show abstract
Population-level immunity to SARS-CoV-2 directly impacts the incidence of COVID-19 morbidity and mortality. Understanding how this immunity is likely to change over time in the context of future vaccination schedules and emerging SARS-CoV-2 variants is critical to inform pandemic policy. This study simulates population-level COVID-19 immunity (including relative contributions of vaccination and previous infection) in Victoria, Australia over 18 months using an agent-based model and logistic regression equations that predict immunity and waning following vaccination and/or infection. Previous infection was found to drive most immunity against infection even with ongoing regular vaccination, however a greater proportion of overall immunity against mortality was accounted for by vaccination. Although previous infection appears to be driving a substantial component of population-level COVID-19 immunity currently, improved vaccines providing longer lasting (and better sterilizing) immunity are likely to be a critical component of the future pandemic response given the risks associated with SARS-CoV-2 infection.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia 96%
- mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia 96%
- Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19 95%
Similar papers in this journal
- Non-pharmaceutical interventions and vaccinating school children required to contain SARS-CoV-2 Delta variant outbreaks in Australia: a modelling analysis 97%
- Potential health and economic impact of paediatric vaccination using next generation influenza vaccines in Kenya: a modelling study 95%
- SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study 94%
Similar papers in this journal
- COVID-19 vaccine uptake and effectiveness by time since vaccination in the Western Cape province, South Africa: An observational cohort study during 2020-2022 94%
- Epidemiological differences in the impact of COVID-19 vaccination in the United States and China 94%
- Heterogeneity in vaccinal immunity to SARS-CoV-2 can be addressed by a personalized booster strategy 94%
Similar papers in this journal
- Dosing interval strategies for two-dose COVID-19 vaccination in 13 low- and middle-income countries of Europe: health impact modelling and benefit-risk analysis 96%
- Cost-Effectiveness of Vaccination Strategies to Control Future Mpox Outbreaks in England 94%
- Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT1262b2 and after booster vaccination with BNT1262b2 or mRNA-1273: a population-based cohort study (COVIDENCE UK) 93%
Similar papers in this journal
- The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: transmission model-based future scenario analysis and economic evaluation 94%
- Effectiveness of one dose of MVA-BN smallpox vaccine against monkeypox in England using the case-coverage method 93%
- Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.